Hepatitis B seroprevalence in hematological oncology patients
Open Access
- 3 March 2020
- journal article
- research article
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (2) , 87-91
Abstract
Objectives: Hepatitis B virus (HBV) infection is still a serious public health problem today. Many factors such as frequent blood transfusion, hemodialysis, sexual contact, sterilization in surgical procedures, etc. are involved in the transmission of hepatitis B virus. In our study, HBV seroprevalence was evaluated retrospectively in order to provide vaccination of anti-HBs negative patients and to determine HBV prophylaxis in patients with hematological malignancy. Methods: A total of 499 patients were included in the study. HBsAg, anti-HBs, anti-HBc IgG, anti-HDV, HBV DNA values were measured by ELISA (enzyme-linked immunosorbent assay, Liason, Diasorin, Italy) with Real-Time PCR (Cobas-Tagman, Roche Switzerland) and recorded. The obtained datas were evaluated by SPSS for Windows 15.00 statistical program. A value of p <0.05 was accepted as a statistical significance value. Results: HBsAg positivity was found to be 3.4% (n = 17) in all patients. Appropriate treatment regimens were started to patients with HBsAg (+). There were 166 (33.3%) patients with anti-HBs (+). One hundred nineteen (23.8%) patients had anti-HBc IgG (+), 40 (33.6%) of them were started a prophylactic treatment regimen. Anti-HBs positivity were reported after vaccination in 48 (16.8%) patients. Occult hepatitis have not been detected in patients with anti-HBc IgG positivity. Conclusions: As a result of this study, anti-HBs negative patients with hematological malignancies were vaccinated. Patients and physicians should be informed about vaccination and hepatitis serology controls of hematological malignancy and other immunosuppressed patients. Sensitivity in this context should be increased in terms of prophylactic treatments.Keywords
This publication has 8 references indexed in Scilit:
- PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENTArquivos de Gastroenterologia, 2016
- HBsAg, Anti-HBs, Anti-HCV and Anti-HIV Seroprevalence of the Patients Applied to Artvin State HospitalViral Hepatitis Journal, 2013
- Seroprevalence of Hepatitis B and C among Oncology Patients in TurkeyJournal of Health, Population and Nutrition, 2012
- Molecular Mechanisms Underlying Occult Hepatitis B Virus InfectionClinical Microbiology Reviews, 2012
- Evaluation of HBsAg, anti-HCV, anti-HIV and VDRL test results in blood donorsJournal of Clinical and Experimental Investigations, 2011
- High prevalence of hepatitis B virus infection in multiple myelomaLeukemia & Lymphoma, 2011
- Hepatitis B outbreak associated with a hematology-oncology office practice in New Jersey, 2009American Journal of Infection Control, 2011
- Worldwide epidemiology of HBV infection, disease burden, and vaccine preventionJournal of Clinical Virology, 2005